By: Kairos Ventures On: September 13, 2022 In: Axial Therapeutics, Portfolio News

Axial Therapeutics announced that A. Stewart Campbell, Ph.D., will participate in a panel entitled “The Next Wave of Targeted...

Read more
By: Kairos Ventures On: September 12, 2022 In: Linnaeus, Portfolio News

Linnaeus Therapeutics announced the presentation of clinical biomarker data from its study of LNS8801 as a monotherapy and in...

Read more
By: Kairos Ventures On: September 8, 2022 In: Portfolio News, Vivodyne

Dr. Jane Goodall and Vivodyne announced that they have delivered a letter to Congress urging its inclusion of the...

Read more
By: Kairos Ventures On: August 4, 2022 In: MemVerge, Portfolio News

Flash Memory Summit (FMS) is pleased to announce its 2022 Best of Show Award winners. This year's awards recognize...

Read more
By: Kairos Ventures On: July 29, 2022 In: Kairos News

Jim Demetriades speaks with MoochFM host Anthony Scaramucci to discuss investing in science and its ability to change the...

Read more

Seed Health and Axial Therapeutics announced a joint development program targeting the microbiome-gut-brain axis for mental health, with the potential...

Read more

Behavioral Signals, a Los Angeles-based software company and provider in Conversational AI technology, announces its partnership with ddCom Systems,...

Read more
By: Kairos Ventures On: July 7, 2022 In: MemVerge, Portfolio News

MemVerge Memory Machine™ has achieved Red Hat OpenShift Operator and container certifications. This is an important step in enabling...

Read more
By: Kairos Ventures On: June 22, 2022 In: Portfolio News, Provivi

Provivi will participate in the World Agri-Tech South America Summit as a Gold Partner, taking place virtually and in...

Read more
By: Kairos Ventures On: June 13, 2022 In: Kairos III, Kairos News

Kairos Ventures, which bankrolls university scientists and invests in startups emerging from their research, said it has raised $58...

Read more